Mimetas focuses on developing organ-on-a-chip technology to model human biology and disease. Their platforms, such as the OrganoPlate®, enable the culture of 3D tissues and organ models, allowing for high-throughput screening and testing of drug compounds in a physiologically relevant environment. Mimetas collaborates with pharmaceutical companies, research institutions, and academic partners to advance personalized medicine and enhance the efficiency of drug development processes.
Resource type
Material
Country
Netherlands
Access requirements
Purchase